Tag Archives: Glatiramer Acetate

Teva loses four patents on Copaxone; alright, what’s the good news?

The News: A US court invalidated four patents covering Teva Pharmaceutical Industries Ltd.’s (Petach Tikva ISR) three-times weekly version of Copaxone (glatiramer acetate) based on obviousness, following a challenge by… Read more »